350 related articles for article (PubMed ID: 14660989)
1. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
2. An assessment of willingness to participate in a randomized trial of arthroscopic knee surgery in patients with osteoarthritis.
Creel AH; Losina E; Mandl LA; Marx RJ; Mahomed NN; Martin SD; Martin TL; Millett PJ; Fossel AH; Katz JN
Contemp Clin Trials; 2005 Apr; 26(2):169-78. PubMed ID: 15837439
[TBL] [Abstract][Full Text] [Related]
3. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
4. Altruism among participants in cancer clinical trials.
Truong TH; Weeks JC; Cook EF; Joffe S
Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
[TBL] [Abstract][Full Text] [Related]
5. Decision-making and breast cancer clinical trials: how experience challenges attitudes.
Mancini J; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; ; Julian Reynier C
Contemp Clin Trials; 2007 Nov; 28(6):684-94. PubMed ID: 17434812
[TBL] [Abstract][Full Text] [Related]
6. Public attitudes regarding willingness to participate in medical research studies.
Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
[TBL] [Abstract][Full Text] [Related]
7. How preliminary data affect people's stated willingness to enter a hypothetical randomized controlled trial.
Ubel PA; Merz JF; Shea J; Asch DA
J Investig Med; 1997 Dec; 45(9):561-6. PubMed ID: 9444883
[TBL] [Abstract][Full Text] [Related]
8. Patients' willingness to participate in placebo-controlled trials of antihypertensive therapy.
Al-Khatib SM; Biswas MS
Am Heart J; 2003 Dec; 146(6):944-5. PubMed ID: 14660983
[No Abstract] [Full Text] [Related]
9. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.
Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB
Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531
[TBL] [Abstract][Full Text] [Related]
10. Participation of pregnant women in clinical trials: will they participate and why?
Rodger MA; Makropoulos D; Walker M; Keely E; Karovitch A; Wells PS
Am J Perinatol; 2003 Feb; 20(2):69-76. PubMed ID: 12660911
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives.
White CD; Hardy JR; Gilshenan KS; Charles MA; Pinkerton CR
Eur J Cancer; 2008 Sep; 44(13):1820-8. PubMed ID: 18550360
[TBL] [Abstract][Full Text] [Related]
12. Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression.
Andresen EL; Wilson KA; Castillo A; Koopman C
Int Clin Psychopharmacol; 2010 Jan; 25(1):7-16. PubMed ID: 19901843
[TBL] [Abstract][Full Text] [Related]
13. Surgical and oncology trials for rectal cancer: who will participate?
Harrison JD; Solomon MJ; Young JM; Meagher A; Hruby G; Salkeld G; Clarke S
Surgery; 2007 Jul; 142(1):94-101. PubMed ID: 17630005
[TBL] [Abstract][Full Text] [Related]
14. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
[TBL] [Abstract][Full Text] [Related]
15. Identifying motivations and barriers to patient participation in clinical trials.
Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
Schutta KM; Burnett CB
Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the understanding and motivations of patients with schizophrenia about participating in a clinical trial.
Chong SA; Ong YY; Subramaniam M; Abdin E; Marx CE; Campbell AV
Contemp Clin Trials; 2009 Sep; 30(5):446-50. PubMed ID: 19393768
[TBL] [Abstract][Full Text] [Related]
18. Patient attitudes toward granting consent to participate in perioperative randomized clinical trials.
Patel A; Wilke HJ; Mingay D; Ellis JE
J Clin Anesth; 2004 Sep; 16(6):426-34. PubMed ID: 15567646
[TBL] [Abstract][Full Text] [Related]
19. Patients' attitudes to the use of placebos: results from a New Zealand survey.
Chen GF; Johnson MH
N Z Med J; 2009 Jun; 122(1296):35-46. PubMed ID: 19652679
[TBL] [Abstract][Full Text] [Related]
20. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
